ACTIVE

PHARMALIA

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

54,8 k €

-41.8% YoY

Gross margin

84,9 k €

-47.6% YoY

Equity

718,9 k €

+8.3% YoY

What does PHARMALIA do?

PHARMALIA is a Private company with limited liability incorporated in 2010. Its main activity is: Management consultancy activities. Its registered office is in Saint-Nicolas.

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0831.479.941

Incorporation

29/11/2010

Legal form

Private company with limited liability

Registered office

Rue Malaise 91
4420 Saint-Nicolas · WallonieSee on map

Contributed capital

12 400,00 €

Latest accounts

31/12/2025

Activities (NACE)

70200Management consultancy activities· main 70220Business and other management consultancy activities 64200Activities of holding companies 64210Activities of holding companies 68100Buying and selling of own real estate 68110Buying and selling of own real estate+2

Signals

ProfitableSolid equityPositive cashflowPositive EBITDA

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 15 financial years

	2025		2024		2023		2022		2021		2020		2019		2018		2017		2016		2015		2014		2013		2012		2011
Income statement
Gross margin	84,9 k €	-47.6%	162,1 k €	+4.3%	155,4 k €	-3.3%	160,7 k €	+18.6%	135,5 k €	+69.1%	80,2 k €	-32.0%	118 k €	+24.3%	94,9 k €	-16.9%	114,3 k €	+22.7%	93,1 k €	+59.7%	58,3 k €	+0.3%	58,1 k €	-1.0%	58,7 k €	+7.1%	54,9 k €	+78.9%	30,7 k €
EBITDA	83,6 k €	-47.1%	158,2 k €	+2.6%	154,1 k €	-3.9%	160,4 k €	+23.5%	129,9 k €	+75.5%	74 k €	-33.6%	111,6 k €	+27.0%	87,9 k €	-20.3%	110,2 k €	+27.9%	86,2 k €	+55.0%	55,6 k €	-1.2%	56,3 k €	-1.7%	57,2 k €	+6.4%	53,8 k €	+80.1%	29,9 k €
Operating result	77 k €	-49.7%	153,1 k €	+1.2%	151,2 k €	-4.9%	159 k €	+23.3%	128,9 k €	+75.8%	73,3 k €	-31.9%	107,7 k €	+28.2%	84 k €	-21.5%	107 k €	+28.2%	83,4 k €	+50.1%	55,6 k €	-1.2%	56,3 k €	-1.1%	56,9 k €	+6.5%	53,5 k €	+81.0%	29,5 k €
Net result	54,8 k €	-41.8%	94,3 k €	+0.5%	93,9 k €	-3.8%	97,6 k €	+29.4%	75,4 k €	+97.9%	38,1 k €	-38.2%	61,7 k €	+42.2%	43,4 k €	-25.8%	58,5 k €	+55.7%	37,5 k €	+115%	17,5 k €	-21.1%	22,2 k €	-7.4%	24 k €	+34.4%	17,8 k €	+349%	-7,2 k €
Balance sheet
Equity	718,9 k €	+8.3%	664 k €	+16.6%	569,7 k €	+19.7%	475,9 k €	+25.8%	378,3 k €	+24.9%	302,9 k €	+14.4%	264,7 k €	+30.4%	203,1 k €	+27.1%	159,7 k €	+57.7%	101,3 k €	+58.9%	63,7 k €	+37.9%	46,2 k €	+44.3%	32 k €	+38.8%	23,1 k €	+340%	5,2 k €
Total assets	1 M €	+10.9%	906,6 k €	+2.6%	884 k €	+5.0%	842,1 k €	+1.4%	830,1 k €	+0.3%	827,4 k €	+0.2%	826,1 k €	-0.5%	830,5 k €	-0.1%	831,7 k €	-0.2%	833,4 k €	-0.0%	833,6 k €	+0.8%	826,6 k €	-1.2%	836,4 k €	-0.1%	837,5 k €	-1.3%	848,3 k €
Cash	3,4 k €	+1856%	171,5 €		0 €	-100%	12,8 k €		–		–		–		718,1 €		–		0 €	-100%	17,1 €	+65.8%	10,3 €	-99.9%	11,1 k €	+1792%	589 €	+242%	172 €
Debts	283,1 k €	+18.4%	239,2 k €	-17.4%	289,6 k €	-20.6%	364,9 k €	-18.6%	448,6 k €	-13.5%	518,8 k €	-7.3%	559,6 k €	-10.2%	623,2 k €	-7.3%	671,9 k €	-8.2%	732,1 k €	-4.9%	769,8 k €	+0.0%	769,8 k €	-3.2%	795,4 k €	-1.2%	805,4 k €	-3.4%	834,1 k €
Other
Workforce	–		0,0 ETP		0,0 ETP		–		–		–		–		–		–		–		–		–		–		–		–

Estimate

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 2 ended

Active mandates

NAJAT FASKA

Director · since 29 novembre 2010

Active

Ended mandates

Najat Faska

Director

Ended

NAJAT FASKA

Manager

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	14/08/2026	27/08/2025	30/09/2024	29/09/2023	30/09/2022	31/08/2021
General meeting	19/06/2026	20/06/2025	21/06/2024	16/06/2023	17/06/2022	18/06/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

16 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	19/06/2026	14/08/2026	French	PDF
Abridged model	31/12/2024	20/06/2025	27/08/2025	French	PDF
Abridged model	31/12/2023	21/06/2024	30/09/2024	French	PDF
Abridged model	31/12/2022	16/06/2023	29/09/2023	French	PDF
Abridged model	31/12/2021	17/06/2022	30/09/2022	French	PDF
Abridged model	31/12/2020	18/06/2021	31/08/2021	French	PDF
Abridged model	31/12/2019	31/08/2020	12/10/2020	French	PDF
Abridged model	31/12/2018	30/06/2019	24/10/2019	French	PDF
Abridged model	31/12/2017	30/06/2018	24/08/2018	French	PDF
Abridged model	31/12/2016	30/06/2017	28/09/2017	French	PDF
Abridged model	31/12/2015	30/06/2016	30/08/2016	French	PDF
Abridged modelCorrection	31/12/2014	19/06/2015	30/09/2015	French	PDF
Abridged model	31/12/2014	19/06/2015	31/08/2015	French	PDF
Abridged model	31/12/2013	30/06/2014	28/08/2014	French	PDF
Abridged model	31/12/2012	30/06/2013	09/10/2013	French	PDF
Abridged model	31/12/2011	30/06/2012	08/08/2012	French	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 1 active · 2 ended

Active mandates

NAJAT FASKA

Director · since 29 novembre 2010

Active

Ended mandates

Najat Faska

Director

Ended

NAJAT FASKA

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Registered office16/05/2012
SIEGE SOCIAL
PDF
Mandates24/10/2011
DEMISSIONS, NOMINATIONS
PDF
Other02/12/2010
RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 202554,8 k €↓
2024
Annual accounts 202494,3 k €↑
2023
Annual accounts 202393,9 k €↓
2022
Annual accounts 202297,6 k €↑
2021
Annual accounts 202175,4 k €↑
2020
Annual accounts 202038,1 k €↓
2019
Annual accounts 201961,7 k €↑
2018
Annual accounts 201843,4 k €↓
2017
Annual accounts 201758,5 k €↑
2016
Annual accounts 201637,5 k €↑
2015
Annual accounts 201517,5 k €↓
2014
Annual accounts 201422,2 k €↓
2013
Annual accounts 201324 k €↑
2012
Annual accounts 201217,8 k €↑
2011
Annual accounts 2011-7,2 k €
29/11/2010
IncorporationPrivate company with limited liability

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

PHARMALIA

Overview

What does PHARMALIA do?

Trend over 15 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline